New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – NephroGenex, Inc. (0001338095) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – NephroGenex, Inc. (0001338095) (Filer)
Filed: 2016-04-07 AccNo: 0001338095-16-000105 Size: 23 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Filing Date: 2016-04-07T17:02:28-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: